Mezzanine Management has successfully exited its investment in Romanian radiotherapy provider Amethyst, selling its stake to The Rohatyn Group, which aims to further accelerate the company's growth in the oncology sector.

Target Information

Amethyst is a prominent Romanian radiotherapy business that specializes in providing advanced cancer treatment services. Founded in 2010, the company has rapidly evolved and now operates nine treatment centers across Romania, France, Italy, Poland, and Austria, serving over 10,000 patients annually. With a commitment to improving patient outcomes, Amethyst leverages innovative technologies and a skilled medical team to offer quality healthcare services.

Industry Overview in Romania

The healthcare sector in Romania, particularly the oncology segment, has witnessed significant growth and transformation in recent years. As the prevalence of cancer increases, the demand for specialized treatment facilities such as radiotherapy has soared. With the government progressively increasing healthcare spending, private investments in this area have become essential to enhance service delivery and technology adoption.

Moreover, Romania's healthcare system is evolving to integrate modern practices and improve patient access. Various international partnerships and investments have driven advancements in medical technologies, paving the